Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries
Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries
Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries
The Saratov Regional Health Ministry has announced a new procurement of insulin aspart for beneficiaries. The medication will be purchased using funds from the regional budget allocated for healthcare development in 2026. A total of 145,650 doses of insulin aspart will be procured at a unit price of 119.68 rubles. The overall cost of the purchase amounts to 17.43 million rubles. The insulin is scheduled for delivery to the Saratov Pharmaceutical Warehouse by 25 August 2026.
The funds for this procurement come from the 2026 regional state programme 'Healthcare Development'. The ministry aims to ensure beneficiaries receive the necessary medication on time. The procurement will provide essential insulin supplies to those in need across the Saratov region. The delivery deadline and budget allocation have been clearly defined to support the initiative.
Pacific Activists Launch Pleasurenesia to Redefine Sexuality Education Through Pleasure
What if pleasure—not fear—was the foundation of sexuality education? A radical new guide by Pacific youth challenges outdated norms to address crises like HIV and teen pregnancy head-on.
Pacific Activists Launch Pleasurenesia to Redefine Sexuality Education
What if pleasure—not fear—was the foundation of sex education? A radical new guide challenges outdated norms to address the Pacific's growing health crises head-on.
Saratov Region Secures 145,650 Insulin Aspart Doses for 2026 Beneficiaries
A 17.43-million-ruble investment will bring life-saving insulin to Saratov's patients. The region's 2026 healthcare budget prioritizes accessibility and delivery efficiency.
Kazakhstan celebrates top healthcare institutions at Astana awards ceremony
From Almaty's top-rated polyclinic to Turkestan's lifesaving emergency services, these awards spotlight Kazakhstan's healthcare transformation. Who made the cut—and why?